CTU: Phase I/II Study to Assess the Safety, tolerability, Pharmacokinetics and efficacy of JSKN033 in Patients with Advanced or Metastatic Solid Malignant Tumors

  • Park, John (Primary Chief Investigator)
  • TAIDI, Gina (Clinical Trial Unit Staff)
  • Martin, Lewis (Clinical Trial Unit Staff)
  • Chapman, Nicola (Clinical Trial Unit Staff)

Project: Research

Project Details

Short titleJSKN033-101
Effective start/end date20/03/2415/02/29